Elizabeth Tindall

Suggest Changes
Learn More
OBJECTIVE To determine the clinical efficacy, safety, and immunogenicity of abatacept (CTLA-4Ig), a selective costimulation modulator, in patients with rheumatoid arthritis (RA) that has remained(More)
  • 1